Synairgen【SNG】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

4.62

買値

4.32

売値

4.92

出来高

1,020

0.00 日の範囲 0.00

3.00 52 週間の範囲 10.62

時価総額

9.304M

前日終値

4.62

始値

時刻

622

4.47

(O)

最終取引時間

19:47:57

財務取引量

VWAP

平均取引量 (3 か月)

268,072

発行済株式数

201,374,975

配当利回り

PER

-1.11

1 株当たり利益 (EPS)

-0.04

歳入

純利益

-8.41M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.synairgen.com

本社

Southampton, Gbr

設立

Synairgen Plc is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker SNG. The last closing price for Synairgen was 4.62p. Over the last year, Synairgen shares have traded in a share price range of 3.00p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.30 million. Synairgen has a price to earnings ratio (PE ratio) of -1.11.

Synairgen plc Exercise of Share Options and Total Voting Rights

Synairgen plc 30 October 2024 Synairgen plc ('Synairgen' or the 'Company') Exercise of Share Options and Total Voting Rights Southampton, UK - 30 October 2024: Synairgen plc (LSE:...

Synairgen plc Results of AGM and Appointment of New Chairman

Synairgen plc 10 October 2024 Synairgen plc ('Synairgen' or the 'Company') Results of Annual General Meeting and Appointment of New Chairman Southampton, UK - 10 October 2024:...

EARNINGS: Hansard Global profit down; Flowtech cuts outlook

The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported b ...

Synairgen plc Interim Results

Synairgen plc 26 September 2024 Synairgen plc ('Synairgen' or the 'Company') Interim results for the six months ended 30 June 2024 Southampton, UK - 26 September 2024: Synairgen plc...

Synairgen plc Appointment of New Chairman and Notice of AGM

Synairgen plc 18 September 2024 Synairgen plc ('Synairgen' or the 'Company') Appointment of New Chairman Posting of Report and Accounts and Notice of AGM Southampton, UK - 18 September...

Synairgen plc Board Change

Synairgen plc 05 September 2024 Synairgen plc ('Synairgen' or the 'Company') Board Change Southampton, UK - 5 September 2024: Synairgen plc (LSE: SNG), the respiratory company...

IN BRIEF: Synairgen slashes costs and focuses on small hospital trials

outh Hampton, England-based drug discovery and development company focused on combatting respiratory disease - In 2023 ...

Synairgen plc 2023 Full Year Results

Synairgen plc 27 June 2024 Synairgen plc ('Synairgen' or the 'Company') Results for the year ended 31 December 2023 Southampton, UK - 27 June 2024: Synairgen plc (LSE: SNG), the...

Synairgen plc Grant of Options

Synairgen plc 15 November 2023 Synairgen plc ('Synairgen' or the 'Company') Grant of Options Southampton, UK - 15 November 2023: Synairgen plc (LSE: SNG), the respiratory...

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

outhampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infecti ...